Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

NCT00200200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Metastases
Colon Cancer
Rectal Cancer

Interventions

DRUG: Bevacizumab HAI plus systemic chemotherapy
DRUG: HAI plus systemic chemotherapy

Sponsor

Memorial Sloan Kettering Cancer Center